DSM resumes animal grade Vitamin A production

Royal DSM, a global purpose-led science-based company, confirms that it is resuming Rovimix® Vitamin A production in Sisseln, Switzerland.

In November 2022, the firm announced a temporary halt to Vitamin A production at the site.

The challenging cost environment cited in 2022 spans energy, raw materials and process material costs, continues in 2023.

Restarting production will allow DSM to serve its loyal customers with animal nutrition premix solutions ahead of the shutdown for lifetime extension work planned for the Vitamin A line this summer.

The ongoing geopolitical and economic turbulence highlights the importance of maintaining resilient vitamin supply which plays a critical role in food security.

DSM is committed to sustainable production of the highest quality feed additives, including the longstanding Rovimix® product range, with a strong production base in Europe, in alignment with the company’s aim to generate sustainable profitable growth.


Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM’s purpose is to create brighter lives for all. DSM’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at https://www.dsm.com/.

Published on

27 February 2023


  • Press release
  • Vitamins
  • Vitamin A

Media Contact

Ryan Hines


You are being redirected.

We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.